chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SX FIRST STARTED WITH A VERY STIFF NECK, FOLLOWED BY DESCENDING STIFFNESS AND JOINT PAIN ( EVERY ) JOINT. AND CONTINUED OVER SEVERAL DAYS , EACH DAY THE STIFFNESS AND PAIN INCREASED. AS A NURSE I TOOK ASA, MOTRIN AND TYLENOL TO GET THRU MY DAY. i USED MY HUSBANDS PRESCRIPTION VICODAN @ NIGHT ON 9/18 & 9/19. BY 9/19 PM I HAD DIFFICULTY WALKING AND PROFOUND WEAKNESS ALONG WITH PAIN, NO GRIP STRENGTH IN EITHER HAND. MY HUSBAND HAD TO DRESS ME, GET ME DOWN 13 STEPS( COULDN'T PICK UP MY FEET OR KNOW WHERE MY FEET WERE LANDING ). HE TOOK ME TO MY PLACE OF EMPLOYMENT. I WAS ADMITTED GIVEN IV FLIUDS, IV PAIN MEDS, PHYSICAL THERAPY, MRI'S AND BLOOD WORK. MY HOSPITAL STAY WAS 9-20-09  TO 9-23-09. I WAS ALSO SEEN BY A NEUROLOGIST. 10/26/2009 records for 9/20/2009. Patient with sx of neck stiffness, diffuse arthralgias and myalgias, weakness, numbness/tingling of hands. PE noted diffuse weakness with decreased ROM of the extremities. Neuro consult 9/21/2009, PE noted gag reflex depressed bilaterally, DTR's rt knee absent, DTR's UE's decreased, DTR's absent in ankles bilaterally with decreased strength all extremities. Tx: IVF, Toradol IV Resp therapy tx's. Suspected dx GBS.
Weakness; 99 degree Fahrenheit fever, but later came back with 100.7 degree Fahrenheit fever; A spontaneous report (United States) was received from a consumer concerning a relative 75-years-old male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced a 99 degree Fahrenheit fever, but later came back with 100.7 degree Fahrenheit fever and weakness.  The patient's medical history was not provided. No concomitant medications were provided.   The patient received their first of two planned doses of mRNA-1273 (Lot/batch number: unknown) on an unspecified date. On 20 Feb 2021, approximately 5 days prior to onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot/batch number: unknown) for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient experienced 99 degree Fahrenheit fever, was treated with paracetamol, but later came back with 100.7 degree Fahrenheit fever. The patient visited emergency room as experienced weakness.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore action taken with the drug in response to the events was not applicable.  The events, a 99 degree Fahrenheit fever, but later came back with 100.7 degree Fahrenheit fever and weakness was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Phone call from stepmom early June 2017 stating that the HPV vaccine had given patient a lot of symptoms including hand tremors, nausea, lethargy, personality changes, bipolar symptoms as well as hives, weight gain, jaw pain, nausea, vomiting and headaches. Patient did not present for medical evaluation.  Patient's current status is undocumented.
Within 8 hours after vaccine administration had sinus tachycardia, acute on chronic renal fail; elevated D Dimer, flushing, new (R) bundle branch blk on EKG.
Information has been received from a 19 year old female with a history of papilloma viral infection and no known allergies or adverse drug reactions reported. On 22 Nov 2006, the patient was vaccinated with Gardasil vaccine (yeast). There were no concomitant medications reported. On 24 Nov 2006, the patient reported "feeling sick to her stomach, developed nausea and had trouble eating starting two days after receiving Gardasil vaccine (yeast) and the experience had lasted until now". The patient reported that there was a "possibility she could be pregnant", but would not know until 05 Dec 2006. At  the time of this report, the patient had not recovered from the events. Additional information has been requested.
On 2/12 morning I was reading and began to see blotches in my vision.  During the day, I got a slight headache on my leftside.  At one point my speech became garbled if I could be speak.  It cleared up a bit through the afternoon but later I began to experience disorientation and fatigue.  I went to the hospital on the evening of 2/12 and was told by the Dr that I suffered a stroke.  I didn't leave the hospital until 2/14 evening.  After the test, they determined I had a TIA.
C/o CP somewhat steady for past 1-2 wks, and some mild upper respiratory Sx's. EKG: Some global PR depression - concern of possible endo or myocarditis. Has been doing lot of listing. Assessment: Costochondritis, PR interval depression.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/11/21pfizer,Lot# 2nd dose: 02/09/21,Pfizer,Lot#  Diagnosed covid positive:07/29/21 Symptom onset:07/28/21 Exposure:Travel Symptoms:Runny nose, congestion
pt is a nurse who stuck self w/ a needle in the course of work @ hosp; pt was given vax & devel allergic reaction around the puncture site & required hospitalization;
adult VAQT A and it was administered to three 15 month old patients; Physicians's office accidently ordered adult VAQTA; adult VAQT A and it was administered to three 15 month old patients; no adverse reactions were reported; This spontaneous report as received from an unspecified reporter concerning a 15-month-old patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  The practice accidently ordered adult hepatitis a vaccine, inactivated (VAQTA) instead of pediatric dose (Product prescribing error).    On an unknown date, the patient was vaccinated with an adult dose of hepatitis a vaccine, inactivated (VAQTA) instead of pediatric dose  for prophylaxis ( dose, route of administration, lot number and expiration date were not reported) (Product administered to patient of inappropriate age, Accidental overdose) .  No adverse reactions were reported per caller.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2105USA004310: US-009507513-2105USA004309:
Client was due for Td - Td administered on Fri March 02, 2007. By Sunday, March 4, injection site red, hot, swollen like an orange.
Pt felt light headed and then lost consciousness.  Pharmacist caught patient and then with help, lowered patient to the floor.  Supportive care performed.  Called EMS, pt vitals within normal range.  EMS left without patient.
He received the vaccine, had fatigue, chills one day, but the arm was not terribly sore.   Then 6 days later had itching bumps/hives that turn red, and just erupts on his hips, groin, arms in places, abdomen, most parts of his body including his scalp and has persisted.   He had it for 4 days and she began giving him Benadryl, which has helped.   He still has these areas and reaction.  He has been having headaches since he's had these reactions.    In Jan/Feb he was having some symptoms, COVID toe, hives, blood shot eye and intestinal problems all at the same time, which they believe he had the COVID virus due to articles that they had read about.  He went to a podiatrist who did not know what he was looking at.  These reactions are similar to the reaction he had when he believes he had the COVID virus.  They live in a ski resort area and they have people coming from all over, and had a lot of friends who had "the flu".    He tried to call his doctor twice to get some advice, and was never able to speak to her and the nurses misunderstood what he was calling for.
This study case was received from the investigator in a trial on 18 July 2013. A 20 year-old male subject with no significant past medical history was found to have idiopathic myocarditis 12 days after the subject had received the following vaccines on 26 August 2009: an injection of ACAM2000 (lot number, route and site of administration not reported), Anthrax 1 (manufacturer, lot number, route and site of administration not reported) and Influenza live intranasal (manufacturer, lot number, route and site of administration not reported). The Troponin I result, ECG and Echocardiogram, Lumbar puncture and MRI of the brain, spinal cord and heart were not available. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Began to sweat profusely; Fever of 99.8F; Blistery rash on stomach, upper thigh which ran out towards hip area; Redness from rash took a few days to go away; Mucus came out of the stye; Developed a stye on right lower eyelid; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (Mucus came out of the stye), HORDEOLUM (Developed a stye on right lower eyelid), RASH VESICULAR (Blistery rash on stomach, upper thigh which ran out towards hip area), HYPERHIDROSIS (Began to sweat profusely) and RASH ERYTHEMATOUS (Redness from rash took a few days to go away) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included ATORVASTATIN, OMEPRAZOLE, METFORMIN, CELECOXIB (CELEBREX), ASCORBIC ACID (VITAMIN C FLAVOUR), CALTRATE + D PLUS, VITAMIN B1 NOS;VITAMIN B12 NOS and SENNA ALEXANDRINA (SENNA-GEN) for an unknown indication.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HORDEOLUM (Mucus came out of the stye) and HORDEOLUM (Developed a stye on right lower eyelid). On 08-Mar-2021, the patient experienced RASH VESICULAR (Blistery rash on stomach, upper thigh which ran out towards hip area) and RASH ERYTHEMATOUS (Redness from rash took a few days to go away). On 10-Mar-2021, the patient experienced HYPERHIDROSIS (Began to sweat profusely) and PYREXIA (Fever of 99.8F). On 05-Mar-2021, HORDEOLUM (Mucus came out of the stye) had resolved. On 08-Mar-2021, HORDEOLUM (Developed a stye on right lower eyelid) had resolved. On 10-Mar-2021, HYPERHIDROSIS (Began to sweat profusely) and PYREXIA (Fever of 99.8F) had resolved. At the time of the report, RASH VESICULAR (Blistery rash on stomach, upper thigh which ran out towards hip area) and RASH ERYTHEMATOUS (Redness from rash took a few days to go away) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Triamcinolone.
Chills; headache; nausea; jaundice; Hemolysis/hemolytic anemia; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EP7583), administered in left arm, on 06Apr2021 at 13:00 (at the age of 33-years-old) at single dose for COVID-19 immunisation. Medical history included hereditary spherocytosis, allergies to sulfa drugs. Patient was not pregnant. No covid prior vaccination. Concomitant medications were not reported. No other vaccines were received in four weeks. The patient previously received the first dose of BNT162b2 (lot number: EN6208) on 14Mar2021 at 04:00 PM (at the age of 33-years-old) administered in left arm for COVID-19 immunization. The patient experienced chills, headache, nausea starting 14 hours after the 2nd dose, on 07Apr2021 at 03:00, and persistent on and off for 5 days. Hemolysis and jaundice started 2-3 days after the shot, in Apr2021, (patient had hemolytic anemia) and had continued to deteriorate 7 days post-vaccine. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures, which included covid test post vaccination, on 11Apr2021, nasal swab (Abbot Rapid Molecular): negative. The patient was recovering from the events.; Sender's Comments: The reported events are assessed as possibly related to the suspect drug BNT162B2 based on strong temporal association, but possible contributory effects from patient's medical history of hereditary spherocytosis cannot be completely ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient called our pharmacy 11/20/06 @215pm and reported that she got sick four days later from receiving a flu vaccine on 11/7. She experienced rash, sore throat, soreness and swelling on tounge. She also reported that her throat closed up. She said she went to the ER and had to take several days off work. She is now stable.
Have to urinate tremendous amount in 45 min intervals; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration on 31Mar2021 at 10:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Patient had no medical history. The patient previously received Z-pak and experienced allergy. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 10Mar2021 at 10:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021, after the second vaccine, the patient had to urinate tremendous amount in 45 minute intervals. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event had to urinate tremendous amount in 45 minute intervals was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning an approximately 12 month old female who on 19-MAR-2010 was vaccinated with a dose of MMR II. Secondary suspect therapy included VARIVAX (MSD) and VAQTA (MSD). Other concomitant therapy included DTaP and PREVNAR. Around nine to ten days after vaccination, on approximately 29-MAR-2010 the patient experienced a low grade fever and rash. The physician believed it was a mild case of either measles or rubella because it did not look like varicella. At the time of the report, the outcome was unknown. Additional information has been requested. This is one of two reports received from the same source.
really bad pain from her groin that went to her hip/pain stuff; right thumb swelled up painfully; memory lost/ can't remember well; really bad pain from her groin that went to her hip; joint pain; pain on the left side of her chest that just came 2-3 weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (really bad pain from her groin that went to her hip/pain stuff), PERIPHERAL SWELLING (right thumb swelled up painfully), CHEST PAIN (pain on the left side of her chest that just came 2-3 weeks ago), AMNESIA (memory lost/ can't remember well) and GROIN PAIN (really bad pain from her groin that went to her hip) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004m20a and 021l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included METFORMIN, MULTIVITAMIN [VITAMINS NOS] and COLECALCIFEROL (VIT D3) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced CHEST PAIN (pain on the left side of her chest that just came 2-3 weeks ago). On 19-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (really bad pain from her groin that went to her hip/pain stuff), PERIPHERAL SWELLING (right thumb swelled up painfully), AMNESIA (memory lost/ can't remember well), GROIN PAIN (really bad pain from her groin that went to her hip) and ARTHRALGIA (joint pain). The patient was treated with IBUPROFEN in April 2021 at an unspecified dose and frequency. At the time of the report, PAIN (really bad pain from her groin that went to her hip/pain stuff), PERIPHERAL SWELLING (right thumb swelled up painfully), CHEST PAIN (pain on the left side of her chest that just came 2-3 weeks ago), AMNESIA (memory lost/ can't remember well), GROIN PAIN (really bad pain from her groin that went to her hip) and ARTHRALGIA (joint pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was about to get booster ,but before which encountered with the events.  Patient also uses blood pressure pills
Pt. recieved COVID vaccine on 6 Feb @0730 and presented to the hospital with chest pain & quesionable stroke.  + CT and transferred to another hospital @ 1430, appears CVA (cerebral vascular accident); Cardioembolic stroke; Cerebrovascular accident (CVA), unspecified mechanism; TIA (transient ischemic attack).  He was discharged on 10 Feb.  Home course unknown
Chill,joint pain, muscle pain, tired begin afternoon after shot and continue to next day. Headache and  indigestion begin next day afternoon. Third day after shot right axillary near breast fear pain and still headach and tired.
Patient began feeling light-headed immediately after receiving shot.  Patient then passed out at clinic site.  BP = 90/58, HR = 56.
Right sided temporal headache that started roughly 1 hour post vaccination, waxed/waned over the next 2 days
Vx 1: swelling, itching and rash on right arm - from shoulder to wrist Vx2: swelling, itching, rash, pins and needles, pain, baseball sized lump on inj site, lumps under skin on right arm, right breast, right side of torso.
1 week to the day of vaccination, a painful, hard bump at injection site appeared along with an itchy red rash. Rash started quarter sized and ended baseball sized in diameter. It lasted 2 weeks.
Chest pain and discomfort accompanied by fast pulse.  Has been continuing now for 2 weeks.  Have visited cardiologist and is monitoring.  EKG normal.  Pain improves when upright and worsens when lying flat.  Mostly presents as dull ache just below left breast.  Possible acute onset pericarditis.
Feeling unwell, ill, epigastric discomfort, trouble speaking  Per pt:   My body reaction to the 3 shots reached the peak after ~12 hours at 9:50 pm, with symptoms including nausea, shortage of breath, rapid heart rate, feeling cold, and shacking of my hands and whole body so that I could not speak to ask for help and was feeling dying A series of symptoms occurred in the past two days, including fatigue, constipation, ear pain, thirsty, weak and pain with both arms. I could not sleep until early morning the last night because of continuous ear pain even I took a pill of Tylenol.
Received vaccine on 10/26 and that night patient states site was itchy and then the next day on 10/27 developed raised, red area and started to increase in swelling and states it is now the size of an apple. Patient has been applying anti-itch cream with relief. Patient states has small bump on inside of lip by teeth, patient unsure if it's related to flu vaccine or not.
Patient developed post nasal drip, chest congestion, headache, fatigue and cough.  He states he had been exposed to the cold and rain prior to his symptoms and thought he had cold symptoms.  He has a history of bronchitis 2 years ago.  He was advised to contact his physician and he did.  he was diagnosed with Bronchitis at this time and given an antibiotic - azythromycin (z-pack) to take.  He had a prior history of Covid 19 virus in October/2020 for 3 weeks.    After taking the antibiotic he felt better.  He is a tennis coach, got rest in the interim and now is doing well.
Out of specification product administered; A spontaneous report was received from a physician concerning a "couple" of patients of unknown age and gender who received Moderna's COVID-19 vaccine (mRNA-1273), who reported the event of "Out of specification product administered"/MedDRA PT: expired vaccine used.   The patients' medical histories were not provided. Concomitant medication use was not provided.   On an unspecified date, a "couple of patients received a dose (unknown which dose) of two planned doses of mRNA-1273 ([LOT number, route and location unknown]) for prophylaxis of COVID-19 infection.   A physician reported that "a couple of patients received their dose at 7 hours". Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event of  "Out of specification product administered" was considered recovered/resolved (date unspecified).; Reporter's Comments: This report refers to a case of Out of specification product administered for mRNA-1273, lot # unknown with no associated AEs.
tested positive for Covid-19 after having both Pfizer vaccinations. His symptoms included fever, cough, runny nose, sinus pressure and headache; tested positive for Covid-19 after having both Pfizer vaccinations. His symptoms included fever, cough, runny nose, sinus pressure and headache; This is a spontaneous report from a non-contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot numbers and expiration dates were not provided), via an unspecified route of administration on an unspecified date at dose 1, single and via an unspecified route of administration on an unspecified date at dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient tested positive for COVID-19 on 27Jul2021 (also reported as 27Jul2020) after having both doses of Pfizer vaccine. His symptoms included fever, cough, runny nose, sinus pressure and headache. He is currently recovering at home. The outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient received first Pfizer vaccine and starting 1 day later developed easy bruising and petechiae  found to be thrombocytopenic with platelet count of 30 then further progressed along with hemolytic anemia  ADAMTS13 activity 0% , clinical picture consistent with acquired thrombotic thrombocytopenia purpura (TTP)  requiring therapy with high dose steroids, plasmapheresis and rituximab